CD38 and neoplasm: Since the enzymatic activity of CD38 (Cyclic ADP-Ribose Hydrolase 1) might contribute to a microenvironment favorable for tumor survival in the bone marrow niche, NBs’ tissue penetration capabilities can be exploited to modulate the enzyme activity of CD38 in the bone marrow with a greater likelihood of success.